drugset / Trial / NCT03620175

Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants

NCT03620175 ↗

Phase 1 Completed 22 enrolled BioMendics, LLC University of Miami · collab
RandomizedSingle-groupSingle-blindTreatment

Summary

TolaSure is a topical gel for the promotion of wound healing. This phase I study will assess the safety, tolerability and clinical effect of TolaSure when applied to skin wounds created by punch biopsy in healthy participants. A total of 26 healthy volunteers, males and females ages 18 years or older, will be enrolled. Subjects will monitored for safety and efficacy over the course of 2 weeks following daily topical administration of TolaSure.

Timeline

Start
2018-07-16
Primary completion
2018-12-12
Completion
2018-12-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator TolaSure Unknown 0.5 % Topical
Comparator TolaSure Unknown 1.5 % Topical
Comparator TolaSure Unknown 5 % Topical

Indications

No indication recorded.